clinical trial

  1. anonymous
    Thread

    NASH

    Nonalcoholic steatohepatitis (NASH) liver fibrosis is the new golden goose in the biotech space. More than 40 companies are taking part in...
    Thread by: anonymous, Mar 20, 2019 at 11:07 AM, 0 replies, in forum: Pharma/Biotech Comp - Gen Discussion |Pharma Sales
  2. anonymous
    Thread

    Alzheimer’s disease trial - Axsome Therapeutics reports positive outcome

    Axsome Therapeutics stock skyrockets on positive outcome from Alzheimer's disease trial...
    Thread by: anonymous, Jan 7, 2019 at 10:42 AM, 0 replies, in forum: Pharma/Biotech Companies - In the News
  3. anonymous
    Thread

    United Therapeutics signs a deal with Arena

    United Therapeutics signs an agreement with Arena in a deal worth $1.2 billion. It will pay $800 million as upfront payment to Arena and $400...
    Thread by: anonymous, Nov 15, 2018 at 2:44 PM, 0 replies, in forum: United Therapeutics
  4. anonymous
    Thread

    AbbVie’s elagolix meet phase III trial target

    AbbVie’s soon-to-become next blockbuster drug ELAGOLIX meet phase III trial target. Source:...
    Thread by: anonymous, Mar 19, 2018 at 2:34 PM, 3 replies, in forum: AbbVie
  5. anonymous
    Thread

    Obesity drug developer took a big step toward FDA approval

    Obesity drug developer, Gila Therapeutics, recently took a big step toward FDA approval for its new weight control treatment, completing its Phase...
    Thread by: anonymous, Oct 26, 2017 at 1:13 PM, 0 replies, in forum: Pharma/Biotech Companies - In the News
  6. ChristophMcLee
    Thread

    J&J discontinuing 2 promised blockbuster drugs

    While I was expecting this fate for sirukumab after Glaxo abandoned its partnership on this drug, talacotuzumab's discontinuation was totally...
    Thread by: ChristophMcLee, Oct 17, 2017 at 10:02 AM, 2 replies, in forum: Pharma/Biotech Comp - Gen Discussion |Pharma Sales
Showing results 1 to 6 of 6